医
China Med Service
Best doctors, yours
Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties
Infectious hemolytic anemia (D59.400x002) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Non-autoimmune hemolytic anemia (D59.400x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled
Other non-autoimmune hemolytic anemia (D59.400) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compil
Atypical hemolytic uremic syndrome (D59.300x002) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compi
Hemolytic-uremic syndrome (D59.300) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Drug-induced enzyme-deficiency anemia (D59.201) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compil
Drug-induced non-autoimmune hemolytic anemia (D59.200) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being
Cold-agglutinin disease (D59.105) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Secondary cold hemolytic anemia (D59.104) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Warm-antibody AIHA = autoantibodies optimally active at 35-40C. Divided into incomplete warm antibodies and warm autoimmune hemolysins. By chemistry: IgG, IgM, IgA; IgG warm antibodies further IgG1/IgG2/IgG3/IgG4.
血液科Cold-antibody AIHA is a subtype of AIHA with autoantibodies optimally active below 30C, especially at 4C. Three subtypes: (1) cold-agglutinin syndrome - antibodies agglutinate RBCs maximally at 4C and activate complement; (2) cold hemolysin; (3) paroxysma
血液科Autoimmune hemolytic anemia (AIHA) is a group of anemias caused by overactive B lymphocytes producing anti-RBC autoantibodies that increase RBC destruction. Sometimes marrow erythropoiesis compensates and no anemia occurs (autoimmune hemolysis, AIH).
血液科Cold-agglutinin hemoglobinuria (D59.100x005) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Chronic cold-agglutinin disease (D59.100x002) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled
Other autoimmune hemolytic anemia (D59.100) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Drug-induced autoimmune hemolytic anemia (D59.000) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being com
Hemolytic anemia = anemia when RBC destruction accelerates and marrow erythropoiesis cannot compensate. If marrow can increase RBC output enough to compensate for shortened RBC survival, no anemia occurs - called compensated hemolytic disease.
血液科Hereditary hemolytic anemia (D58.900) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Hereditary stomatocytosis (D58.801) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Stomatocytosis (D58.800x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
|
